我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

抽象的

Advancements in Bladder Cancer Surgery

Hayes Joseph

Transurethral resection of bladder tumors (TURBT) remains a vital diagnostic and early-stage treatment tool. Robotic-assisted radical cystectomy (RARC) demonstrates benefits over open surgery, including reduced blood loss and shorter hospital stays. Laparoscopic and endoscopic procedures, such as single-port and NOTES, show promise in select cases. Personalized medicine, driven by genomics and molecular profiling, enables tailored treatment strategies based on tumor characteristics. Collaborative efforts among urologists, oncologists, and other healthcare professionals are essential for optimizing patient outcomes. These advancements offer new prospects for improved prognosis and quality of life in bladder cancer patients.

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证。